Artificial Intelligence–Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial
Open Access
- 15 July 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e042106
Abstract
Background: Atrial fibrillation (AF) is often underdiagnosed and undertreated by noncardiologists. This study evaluated whether artificial intelligence–enabled ECG (AI‐ECG) alerts could improve AF diagnosis and non–vitamin K antagonist oral anticoagulant prescriptions by noncardiologists. Methods: In this open‐label, cluster randomized controlled trial (NCT05127460) at 2 hospitals in Taiwan, noncardiologists were randomized to an intervention group (AI‐ECG alerts) or control group (usual care). Alerts were sent to physicians when AI‐ECG identified AF in emergency or hospitalized patients at risk of stroke (CHA₂DS₂‐VASc ≥1 for men, ≥2 for women), excluding those with prior AF or oral anticoagulant use. Primary end points included a non–vitamin K antagonist oral anticoagulant prescription within 90 days after discharge, new AF diagnosis, echocardiogram arrangements, and cardiologist visits. Secondary end points were ischemic stroke, cardiovascular death, and all‐cause death. Results: A total of 8857 and 8960 patients were treated by 120 and 113 noncardiologists in the intervention and control groups, respectively; 275 and 245 patients had AI‐detected AF. The non–vitamin K antagonist oral anticoagulant prescription rate was significantly higher in the intervention group (23.3% versus 12.0%; hazard ratio [HR], 1.85 [95% CI, 1.11–3.07]). The intervention group also had a higher rate of AF diagnosis (HR, 1.40 [95% CI, 1.03–1.90]). No significant differences were observed in echocardiogram arrangements, cardiologist visits, or the rates of ischemic stroke, cardiovascular death, and all‐cause death. Conclusions: An AI‐ECG alert for AF identification promoted non–vitamin K antagonist oral anticoagulant prescriptions among noncardiologists, thus reducing the disparity in AF care quality between cardiologists and noncardiologists. Registration: URL: https://clinicaltrials.gov/ ; Unique identifier: NCT05127460.Keywords
This publication has 31 references indexed in Scilit:
- Barriers to Guideline-Directed Anticoagulation in Patients With Atrial Fibrillation: New Approaches to an Old ProblemCanadian Journal of Cardiology, 2023
- How is atrial fibrillation detected in everyday healthcare? Results of a Dutch cohort studyNetherlands Heart Journal, 2022
- A Deep-Learning Algorithm-Enhanced System Integrating Electrocardiograms and Chest X-rays for Diagnosing Aortic DissectionCanadian Journal of Cardiology, 2022
- Performance of a Convolutional Neural Network and Explainability Technique for 12-Lead Electrocardiogram InterpretationJAMA Cardiology, 2021
- Mobile Health Technology to Improve Care for Patients With Atrial FibrillationJACC, 2020
- Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) PathwayThe American Journal of Medicine, 2018
- Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac SurgeryJACC, 2018
- Learning and teaching electrocardiography in the 21st century: A neglected artJournal of Electrocardiology, 2018
- 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillationJournal of the Formosan Medical Association, 2016
- Misdiagnosis of atrial fibrillation and its clinical consequencesThe American Journal of Medicine, 2004